CIK: 0001802528 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $885,124 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 2,360,077 | $189,986 | 21.5% | $49.79 | +48.7% | COM | 05464T104 |
| NUVL | NUVALENT INC | 1,924,626 | $146,002 | 16.5% | $22.67 | +213.8% | COM | 670703107 |
| SYRE | SPYRE THERAPEUTICS INC | 4,018,101 | $94,466 | 10.7% | $31.80 | +6.1% | COM NEW | 00773J202 |
| APGE | APOGEE THERAPEUTICS INC | 2,048,647 | $80,614 | 9.1% | $22.03 | +120.3% | COM | 03770N101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,202,798 | $74,849 | 8.5% | $18.66 | +12.8% | COM | 29337E102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,762,837 | $71,502 | 8.1% | $15.37 | +56.4% | COM | 252828108 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 3,204,841 | $59,834 | 6.8% | $18.73 | 0.0% | ORD SHS CL A | G52694109 |
| COGT | COGENT BIOSCIENCES INC | 6,225,641 | $52,482 | 5.9% | $8.53 | -11.1% | COM | 19240Q201 |
| — | ASTRIA THERAPEUTICS INC | 3,554,129 | $32,343 | 3.7% | $9.99 | — | COM | 04635X102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 931,890 | $32,290 | 3.6% | $27.21 | +7.6% | COM | 74366E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,845,813 | $24,014 | 2.7% | $16.72 | -17.2% | COM | 92790C104 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,069,199 | $21,641 | 2.4% | $20.24 | — | SPONSORED ADS | 088786108 |
| TERN | TERNS PHARMACEUTICALS INC | 748,996 | $5,101 | 0.6% | $3.72 | +63.0% | COM | 880881107 |